- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:58 | Trial of Boehringer's cystic fibrosis gene therapy imminent | ||
| 13:58 | NICE backs consolidation use of Blincyto in leukaemia | ||
| 12:58 | Poolbeg slumps as Hookipa merger is called off | ||
| 12:58 | AstraZeneca builds in China as Cosette buys Mayne | ||
| 10:58 | Kennedy delays first vaccine expert meeting under his watch | ||
| Do | NICE changes its mind on BMS' lymphoma cell therapy | ||
| Do | Boehringer eyes third quarter FDA verdict for oral HER2 drug | ||
| Do | Pharma lobbies Trump as 25% tariff on imports looms | ||
| Do | SMA treatment with Evrysdi 'could start prenatally' | ||
| Do | UCB's non-cannabis drug for severe epilepsy gets NHS okay | ||
| Mi | Biogen bags rights to epilepsy drug from Stoke in $550m deal | ||
| Mi | Supernus reports less than super data for depression drug | ||
| Mi | FDA sets June date for Gilead's twice-yearly HIV PrEP | ||
| Mi | When licensing deals go bad - Novo sues KBP Bio for $830m | ||
| Mi | RFK 'willing to be wrong' on vaccines, but a probe is coming | ||
| Di | Shionogi gets approval in Japan for ADHD digital therapeutic | ||
| Di | Can Dupixent plug treatment gap in bullous pemphigoid? | ||
| Di | Four more drugs in keenly watched ALS trial miss the mark | ||
| Di | First biosimilar fast-acting insulin reaches US market | ||
| Di | Bill would allow AIs to prescribe FDA-approved drugs | ||
| Mo | Bavarian Nordic chikungunya vaccine gets FDA okay | ||
| Mo | Istesso backer sees silver lining in failed arthritis trial | ||
| Mo | GSK gets ready for its next big vaccine launch | ||
| Mo | Ono poised to join Daiichi in TGCT market after FDA nod | ||
| Mo | US federal job cuts reach the FDA, CDC, say reports |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
